Alyssa Shell Tilhou, MD, PhD

Assistant Professor, Family Medicine

Alyssa Tilhou
617.414.4465
771 Albany Street

Biography

Dr. Tilhou is a family physician, addiction specialist and health services researcher in the Department of Family Medicine at Boston Medical Center. She is also the department’s Research Director. Her research focuses on access and utilization of primary care and substance use services in low-income populations. Dr. Tilhou completed her medical education and doctorate in Population Health Sciences at the University of Texas Medical Branch, residency in family medicine at the Mountain Area Health Education Center in Asheville, NC, and a fellowship in Addiction Medicine at the University of Wisconsin. She is supported by a K08 from the National Institute on Drug Abuse. Other recent funding includes a BU CTSI pilot award to study disparities in buprenorphine quality indicators among BMC patients and a contract with the Wisconsin Department of Health Services through which she is evaluating disparities in telehealth uptake among WI Medicaid patients during the COVID-19 pandemic.

Education

  • Harvard University, AB
  • University of Texas Medical Branch, MD/PhD

Publications

  • Published on 1/2/2024

    Tilhou AS, Jain A, DeLeire T. Telehealth Expansion, Internet Speed, and Primary Care Access Before and During COVID-19. JAMA Netw Open. 2024 Jan 02; 7(1):e2347686. PMID: 38180762.

    Read at: PubMed
  • Published on 12/28/2023

    Tilhou AS, Zaborek J, Baltes A, Salisbury-Afshar E, Malicki J, Brown R. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs. Subst Use Misuse. 2024; 59(2):254-257. PMID: 37807227.

    Read at: PubMed
  • Published on 10/13/2023

    Tilhou AS, Murray E, Wang J, Linas BP, White L, Samet JH, LaRochelle M. Trends in buprenorphine dosage and days supplied for new treatment episodes for opioid use disorder, 2010-2019. Drug Alcohol Depend. 2023 Nov 01; 252:110981. PMID: 37839942.

    Read at: PubMed
  • Published on 10/8/2023

    Alyssa S Tilhou, Jen Zaborek, Amelia Baltes, Elizabeth Salisbury-Afshar, Julia Malicki Randall Brown. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs. Substance Use & Misuse. 2023; (1-4).

  • Published on 8/26/2023

    Tilhou AS, Saloner B, DeLeire T, Chakraborty S, Dague L. Health and Healthcare Access for Essential, Nonessential, and Nonworkers During the COVID-19 Pandemic. J Occup Environ Med. 2023 Nov 01; 65(11):e703-e709. PMID: 37641177.

    Read at: PubMed
  • Published on 3/28/2023

    Tilhou AS, Zaborek J, Baltes A, Salisbury-Afshar E, Malicki J, Brown R. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking. Harm Reduct J. 2023 Mar 28; 20(1):41. PMID: 36978170.

    Read at: PubMed
  • Published on 3/28/2023

    Tilhou AS, Zaborek J, Baltes A, Salisbury-Afshar E, Malicki J, Brown R. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking. Harm Reduct J. 2023 Mar 28; 20(1):41. PMID: 36978170.

    Read at: PubMed
  • Published on 1/1/2023

    Tilhou, Alyssa Shell, Eleanor Murray, Jiayi Wang, Benjamin P. Linas, Laura White, Jeffrey H. Samet, and Marc LaRochelle. Trends in buprenorphine dosage and days supplied for new treatment episodes for opioid use disorder, 2010–2019. Drug and Alcohol Dependence. 2023; 252.

  • Published on 12/15/2022

    Tilhou AS, Birstler J, Baltes A, Salisbury-Afshar E, Malicki J, Chen G, Brown R. Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin. Harm Reduct J. 2022 Dec 15; 19(1):142. PMID: 36522777.

    Read at: PubMed
  • Published on 7/12/2022

    Tilhou AS, Glass JE, Hetzel SJ, Shana OE, Borza T, Baltes A, Deyo BMF, Agarwal S, O'Rourke A, Brown RT. Association between spine injury and opioid misuse in a prospective cohort of Level I trauma patients. OTA Int. 2022 Sep; 5(3). PMID: 36275837.

    Read at: PubMed

View 5 more publications: View full profile at BUMC

View all profiles